MedWatch

Novo Nordisk unsure about chance of reaching upper growth target: "This would require significant changes"

With two months until New Year, Novo Nordisk still does not know whether this year will generate a 5 or 8 percent sales growth. Most likely, it will land somewhere in the middle.

Novo Nordisk Chief Financial Officer Karsten Munk Knudsen | Photo: Novo Nordisk / PR

2020 only has two months left, but the Covid-19 pandemic is generating so much uncertainty Novo Nordisk cannot predict whether it will land on a 5, 6, 7 or 8 percent growth in revenue this year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs